The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche
Gliomas are devastating brain cancers that have poor prognostic outcomes for their patients. Short overall patient survival is due to a lack of durable, efficacious treatment options. Such therapeutic difficulties exist, in part, due to several glioma survival adaptations and mechanisms, which allow...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/11/2342 |
id |
doaj-7bd3ed2c0407442fa30d05b852ce97c4 |
---|---|
record_format |
Article |
spelling |
doaj-7bd3ed2c0407442fa30d05b852ce97c42020-11-25T02:17:56ZengMDPI AGInternational Journal of Molecular Sciences1422-00672017-11-011811234210.3390/ijms18112342ijms18112342The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular NicheMohammed Diksin0Stuart J. Smith1Ruman Rahman2Children’s Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UKChildren’s Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UKChildren’s Brain Tumour Research Centre, School of Medicine, University of Nottingham, Nottingham NG7 2UH, UKGliomas are devastating brain cancers that have poor prognostic outcomes for their patients. Short overall patient survival is due to a lack of durable, efficacious treatment options. Such therapeutic difficulties exist, in part, due to several glioma survival adaptations and mechanisms, which allow glioma cells to repurpose paracrine signalling pathways and ion channels within discreet microenvironments. These Darwinian adaptations facilitate invasion into brain parenchyma and perivascular space or promote evasion from anti-cancer defence mechanisms. Ultimately, this culminates in glioma repopulation and migration at distances beyond the original tumour site, which is a considerable obstacle for effective treatment. After an era of failed phase II trials targeting individual signalling pathways, coupled to our increasing knowledge of glioma sub-clonal divergence, combinatorial therapeutic approaches which target multiple molecular pathways and mechanisms will be necessary for better treatment outcomes in treating malignant gliomas. Furthermore, next-generation therapy which focuses on infiltrative tumour phenotypes and disruption of the vascular and perivascular microenvironments harbouring residual disease cells offers optimism for the localised control of malignant gliomas.https://www.mdpi.com/1422-0067/18/11/2342glioblastomatumour invasionperivascular nicheextracellular matrixchemokine |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Mohammed Diksin Stuart J. Smith Ruman Rahman |
spellingShingle |
Mohammed Diksin Stuart J. Smith Ruman Rahman The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche International Journal of Molecular Sciences glioblastoma tumour invasion perivascular niche extracellular matrix chemokine |
author_facet |
Mohammed Diksin Stuart J. Smith Ruman Rahman |
author_sort |
Mohammed Diksin |
title |
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche |
title_short |
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche |
title_full |
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche |
title_fullStr |
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche |
title_full_unstemmed |
The Molecular and Phenotypic Basis of the Glioma Invasive Perivascular Niche |
title_sort |
molecular and phenotypic basis of the glioma invasive perivascular niche |
publisher |
MDPI AG |
series |
International Journal of Molecular Sciences |
issn |
1422-0067 |
publishDate |
2017-11-01 |
description |
Gliomas are devastating brain cancers that have poor prognostic outcomes for their patients. Short overall patient survival is due to a lack of durable, efficacious treatment options. Such therapeutic difficulties exist, in part, due to several glioma survival adaptations and mechanisms, which allow glioma cells to repurpose paracrine signalling pathways and ion channels within discreet microenvironments. These Darwinian adaptations facilitate invasion into brain parenchyma and perivascular space or promote evasion from anti-cancer defence mechanisms. Ultimately, this culminates in glioma repopulation and migration at distances beyond the original tumour site, which is a considerable obstacle for effective treatment. After an era of failed phase II trials targeting individual signalling pathways, coupled to our increasing knowledge of glioma sub-clonal divergence, combinatorial therapeutic approaches which target multiple molecular pathways and mechanisms will be necessary for better treatment outcomes in treating malignant gliomas. Furthermore, next-generation therapy which focuses on infiltrative tumour phenotypes and disruption of the vascular and perivascular microenvironments harbouring residual disease cells offers optimism for the localised control of malignant gliomas. |
topic |
glioblastoma tumour invasion perivascular niche extracellular matrix chemokine |
url |
https://www.mdpi.com/1422-0067/18/11/2342 |
work_keys_str_mv |
AT mohammeddiksin themolecularandphenotypicbasisofthegliomainvasiveperivascularniche AT stuartjsmith themolecularandphenotypicbasisofthegliomainvasiveperivascularniche AT rumanrahman themolecularandphenotypicbasisofthegliomainvasiveperivascularniche AT mohammeddiksin molecularandphenotypicbasisofthegliomainvasiveperivascularniche AT stuartjsmith molecularandphenotypicbasisofthegliomainvasiveperivascularniche AT rumanrahman molecularandphenotypicbasisofthegliomainvasiveperivascularniche |
_version_ |
1724884175795781632 |